Momentum Public Relations
Press Release: May 8, 2019
Mondias Naturals Inc. (“Mondias” or the “Company”) (TSXV: NHP) is pleased to announce the appointment of Mr. André Rancourt as Executive Chairman, and of Mr. Derek Lindsay as Vice President, Corporate Development, effective immediately. Mr. Rancourt was previously Chairman of the Board.
“The appointment of Mr. Rancourt as Executive Chairman clearly strengthens the structure and depth of our management,” said Jean-Philippe Gravel, Chief Executive Officer of Mondias. “Mr. Rancourt’s wealth of expertise, vast network and involvement in day-to-day strategy and operations will greatly contribute to our expansion efforts.”
“We are also pleased to have Mr. Lindsay join the Mondias team. His proven expertise in raising equity and financing projects, structuring creative strategic partnerships, increasing investor awareness and completing acquisitions will be an asset for Mondias as the Company embarks on its next growth phase,” added Mr. Gravel.
Mr. Lindsay is a seasoned financial executive with extensive international experience in accelerating the growth of emerging companies. Over the course of his career, he has been instrumental in raising significant equity and debt financing, completing acquisitions and closing strategic partnerships. Mr. Lindsay holds an M.B.A. from the Tuck School of Business at Dartmouth College and a B.A. from Middlebury College, U.S.A.
Mr. Lindsay’s responsibilities with Mondias include financing, investor relations and acquisition activities, as well as participating in the identification and assessment of new business opportunities, with the goal of accelerating the Company’s growth.
The Company also announces that the board of directors has approved the granting of 650,000 stock options to directors, officers, consultants and employees under the Company’s stock option plan. The exercise price of the options is $0.235 (the closing price of the shares on May 6, 2019). The options will vest in equal instalments over a three-year period and expire on May 6, 2029. The options and the stock option plan are subject to shareholder approval at Mondias’ annual and special shareholder meeting on June 10, 2019.
Pursuant to this stock option grant, the Company has a total of 3,600,408 stock options outstanding, which represents less than 6% of the Company’s issued and outstanding common shares.
About Mondias Natural Products Inc.
Mondias specializes in the commercialization and development of evidence-based botanical products for the health care, bio-agriculture and organic markets. The company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. Mondias is also developing botanical-based specialty fertilizers for use on household plants, lawns and golf courses and in urban gardens, nurseries and greenhouses, in collaboration with McGill’s Faculty of Agricultural and Environmental Sciences.
For more information, visit: mondias.ca